Related Experiment Videos
Antimicrobial susceptibility of Clostridium difficile by E test
1Department of Laboratory Medicine, Provincial Taoyuan General Hospital, Taiwan, ROC.
Summary
Metronidazole, teicoplanin, and vancomycin show strong activity against Clostridium difficile. Resistance is high for common antibiotics like imipenem and clindamycin, necessitating careful treatment choices.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Clostridium difficile infection (CDI) is a significant healthcare concern.
- Antimicrobial resistance in C. difficile poses a therapeutic challenge.
Purpose of the Study:
- To evaluate the in vitro activity of 11 antimicrobials against clinical isolates of Clostridium difficile.
- To identify effective agents for treating CDI and assess resistance patterns.
Main Methods:
- Minimum Inhibitory Concentrations (MICs) were determined using E test methodology.
- Testing was performed on 44 clinical isolates of Clostridium difficile.
Main Results:
- Metronidazole (MIC90 0.38 µg/mL), teicoplanin (MIC90 0.75 µg/mL), and vancomycin (MIC90 1.0 µg/mL) demonstrated high in vitro activity.
- Significant resistance was observed for imipenem, cefoxitin, clindamycin, and ciprofloxacin.
Conclusions:
- Teicoplanin shows promise for C. difficile infection treatment and warrants further clinical trials.
- Commonly used antibiotics for anaerobic infections require careful consideration due to emerging resistance and potential for CDI.
- C. difficile-associated diarrhea necessitates vigilance when prescribing certain antibiotics.